Louis F. Stancato

Indiana Biosciences Research Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

40h-index5.0kcitations155works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microtubule and mitosis dynamics(23), Melanoma and MAPK Pathways(22), Neuroblastoma Research and Treatments(22), Cytokine Signaling Pathways and Interactions(18), Heat shock proteins research(13)

Publications155 total

Generation and characterization of iPSC‐derived microglia for in vitro modeling of stimuli‐specific neuroimmune responses
Alzheimer s & Dementia·2026Open Access
Abstract 5469: ITCC-P4, a preclinical proof-of-concept drug testing platform as a tool for pharmacological screening in pediatric tumor models
Cancer Research·2024
Abstract 234: ITCC-P4: Genomic profiling and analyses of pediatric patient tumor and patient-derived xenograft (PDX) models for high throughput <i>in vivo</i> testing
Cancer Research·2023· 1 cited
Abstract 3524: Pharmacological characterization of pediatric brain tumor PDX models in a single mouse trial format
Cancer Research·2023
Supplementary Figure 2 from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
Data from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
Supplementary Materials and Methods from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Figure 2 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
2023Open Access
Supplementary Figure 1 from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
Supplementary Figure 3 from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
Supplementary Figure 2 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
2023Open Access
Data from A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators
2023Open Access
Supplementary Figure Legends 1-4 from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
Supplementary Figure 4 from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
Data from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Figures from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Materials and Methods from Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
2023Open Access
Supplementary Figure Legends 1-4 from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
Data from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
2023Open Access
Supplementary Figure 4 from Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Michele Dowless(16), William B. Pratt(13), Wayne Blosser(11), Andrew C. Larner(6), Richard Jove(5), Jennifer R. Stephens(5), Caitlin D. Lowery(5), Jeremy R. Graff(4), Stephen H. Parsons(4), Priti Krishna(4), Janet Owens‐Grillo(4), Philip W. Iversen(4), Courtney M. Tate(4), Luigi Maria Larocca(4), Ruggero De Maria(4), Roberto Pallini(4), Lucia Ricci‐Vitiani(4), Julie Stewart(4), Jonathan Low(4), Bruce W. Konicek(3)